GenMark Diagnostics Inc. (GNMK) is Trading Lower on Unusual Volume for January 19

Equities Staff |

GenMark Diagnostics Inc. (GNMK) experienced unusually high volume on Jan. 19, as the stock lost 6.27% to a closing price of $6.73. The stock saw 340,306 shares trade hands over the course of the day on 2,216 trades. Given that the stock’s average daily volume over the last month has been 207,828 shares a day, this represents a pretty substantial spike over the norm.

GenMark Diagnostics Inc. has a P/B ratio of 5.26. The stock has traded between $14.11 and $4.63 over the last 52-weeks, its 50-day SMA is now $7.46, and its 200-day SMA $8.89.

GenMark Diagnostics Inc is a molecular diagnostics company. The Company develops and commercializes its proprietary eSensor detection technology for the support of instruments and molecular tests.

Headquartered in Carlsbad, CA, GenMark Diagnostics Inc. has 195 employees and is currently under the leadership of CEO Hany Massarany.

For a complete fundamental analysis analysis of GenMark Diagnostics Inc., check out’s Stock Valuation Analysis report for GNMK. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…